NJC
Paper
18 P. Brown, C. P. Butts, R. Dyer, J. Eastoe, I. Grillo, F. Guittard, 42 H. Mizuuchi, V. Jaitely, S. Murdan and A. T. Florence, Eur. J.
S. Rogers and R. Heenan, Langmuir, 2011, 27, 4563–4571. Pharm. Sci., 2008, 33, 326–331.
19 M. Blesic, A. Lopes, E. Melo, Z. Petrovski, N. V. Plechkova, 43 V. Jaitely, A. Karatas and A. T. Florence, Int. J. Pharm., 2008,
J. N. Canongia Lopes, K. R. Seddon and L. B. N. Rebelo,
J. Phys. Chem. B, 2008, 112, 8645–8650.
354, 168–173.
´
´
44 L. Viau, C. Tourne-Peteilh, J.-M. Devoisselle and A. Vioux,
20 C. A. Lipinski, J. Pharmacol. Toxicol. Methods, 2000, 44,
235–249.
21 R. N. Gupta, R. Gupta and G. S. Rathore, Int. J. Drug Dev.
Res., 2009, 1, 10–18.
22 C.-K. Kim and J.-S. Park, Am. J. Drug Delivery, 2004, 2,
113–130.
23 W. L. Hough, M. Smiglak, H. Rodriguez, R. P. Swatloski,
S. K. Spear, D. T. Daly, J. Pernak, J. E. Grisel, R. D. Carliss,
M. D. Soutullo, J. H. Davis, Jr. and R. D. Rogers, New J.
Chem., 2007, 31, 1429–1436.
24 W. L. Hough and R. D. Rogers, Bull. Chem. Soc. Jpn., 2007,
80, 2262–2269.
25 J. Stoimenovski, P. M. Dean, E. I. Izgorodina and
D. R. MacFarlane, Faraday Discuss., 2012, 154, 335–352.
26 R. Ferraz, L. C. Branco, I. M. Marrucho, J. M. M. Arau´jo,
Chem. Commun., 2009, 46, 228–230.
45 C. Ghatak, V. G. Rao, S. Mandal, S. Ghosh and N. Sarkar,
J. Phys. Chem. B, 2012, 116, 3369–3379.
46 A. Lemke, A. Kinderlen and O. Kayser, Appl. Microbiol.
Biotechnol., 2005, 68, 151–162.
47 R. Mellaerts, R. Mols, J. A. G. Jammaer, C. A. Aerts,
P. Annaert, J. Van Humbeeck, G. Van den Mooter,
P. Augustijns and J. A. Martens, Eur. J. Pharm. Biopharm.,
2008, 69, 223–230.
48 APEX 2 AXScale and SAINT, version 2010, Bruker AXS, Inc.,
Madison, WI, 2012 (accessed 07-16-2012).
49 SADABS, An empirical absorption correction program, v.2.01.,
Bruker AXS Inc., Madison, WI, 2001.
50 G. M. Sheldrick, SHELXTL, structure determination software
suite, v.6.10., Bruker AXS Inc., Madison, WI, 2001.
`
L. P. N. Rebelo, M. N. da Ponte, C. Prudencio, J. P. Noronha 51 C. F. Macrae, I. J. Bruno, J. A. Chisholm, P. R. Edgington,
and Z. Petrovski, Med. Chem. Commun., 2012, 3, 494–497.
27 J. Stoimenovski and D. R. MacFarlane, Chem. Commun.,
2011, 47, 11429–11431.
P. McCabe, E. Pidcock, L. Rodriguez-Monge, R. Taylor, J. van
de Streek and P. A. Wood, J. Appl. Crystallogr., 2008, 41,
466–470.
28 J. Stoimenovski, D. R. MacFarlane, K. Bica and R. D. Rogers, 52 United States Pharmacopeia and National Formulary, United
Pharm. Res., 2010, 27, 521–526.
29 K. G. Mooney, M. A. Mintun, K. J. Himmelstein and
V. J. Stella, J. Pharm. Sci., 1981, 70, 13–21.
30 K. G. Mooney, M. A. Mintun, K. J. Himmelstein and
V. J. Stella, J. Pharm. Sci., 1981, 70, 22–32.
States Pharmacopeial Convention Inc., Rockville, MD, USA,
26th edn, 2003.
53 United States Pharmacopeia and National Formulary, United
States Pharmacopeial Convention Inc., Rockville, MD, USA,
30th edn, 2007.
31 R. P. Swatloski, S. K. Spear, J. D. Holbrey and R. D. Rogers, 54 B. G. Yu, T. Okano, K. Kataoka and G. Kwon, J. Controlled
J. Am. Chem. Soc., 2002, 124, 4974–4975. Release, 1998, 53, 131–136.
32 R. P. Swatloski, S. K. Spear, J. D. Holbrey and R. D. Rogers, 55 Y. Xu, J. Yao, C. Wang and H. Li, J. Chem. Eng. Data, 2012,
in Molten Salts XIII, Proceedings of the thirteenth international 57, 298–308.
symposium on molten salts, ed. H. C. De Long, 56 Y. Yi, H. J. Yoon, B. O. Kim, M. Shim, S.-O. Kim, S.-J. Hwang
R. W. Bradshaw, M. Matsunaga, G. R. Stafford and
P. C. Truelove, 2002, pp. 155–165.
33 Y. Qin, X. Lu and R. D. Rogers, Green Chem., 2010, 12,
968–971.
and M. H. Seo, J. Controlled Release, 2007, 117, 59–67.
57 B. Van Eerdenbrugh, J. Vermant, J. A. Martens, L. Froyen,
J. Van Humbeeck, G. Van den Mooter and P. Augustijns,
Mol. Pharmaceutics, 2010, 7, 1858–1870.
34 M. Neouze, J. Mater. Sci., 2010, 20, 9593–9607.
35 J. Dupont, Acc. Chem. Res., 2011, 44, 1223–1231.
58 J. Lee, J.-Y. Choi and C. H. Park, Int. J. Pharm., 2008, 355,
328–226.
36 P. D. McCrary, P. A. Beasley, O. A. Cojocaru, S. Schneider, 59 F. Kazemi, A. R. Massah and M. Javaherian, Tetrahedron,
T. W. Hawkins, J. P. L. Perez, B. W. McMahon, M. Pfeil, 2007, 63, 5083–5087.
J. A. Boatz, S. L. Anderson, S. F. Son and R. D. Rogers, Chem. 60 C. W. Lindsley, Z. Zhao, R. C. Newton, W. H. Leister and
Commun., 2012, 48, 4311–4313. K. A. Strauss, Tetrahedron Lett., 2002, 43, 4467–4470.
37 P. D. McCrary, P. A. Beasley, S. A. Alaniz, C. S. Griggs, 61 A. R. Xu, J. J. Wang and H. Y. Wang, Green Chem., 2010, 12,
R. M. Frazier and R. D. Rogers, Angew. Chem., Int. Ed.,
2012, 57, 9784–9787.
38 K. Fujita, D. R. MacFarlane and M. Forsyth, Chem. Commun.,
2005, 4804–4806.
39 K. Bica, P. Gaertner and R. D. Rogers, Green Chem., 2011, 13,
1997–1999.
40 K. B. Smith, R. H. Bridson and G. A. Leeke, J. Chem. Eng.
Data, 2011, 56, 2039–2043.
268–275.
62 H. Wang, G. Gurau and R. D. Rogers, Chem. Soc. Rev., 2012,
41, 1519–1537.
63 N-Hexylamine; MSDS, No. W424101, Sigma-Aldrich, St. Louis,
MO, March 31, 2013.
64 (a) A. Lavasanifar, J. Samuel and G. S. Kwon, J. Controlled
Release, 2001, 53, 155; (b) W. Tiyaboonchai, J. Woiszwillo
and C. R. Middaugh, J. Pharm. Sci., 2001, 90, 902;
(c) G. S. Kwon, Crit. Rev. Ther. Drug Carrier Syst., 2003,
20, 357.
41 C. Lourenco, C. I. Melo, R. Bogel-Lukasik and E. Bogel-
Lukasik, J. Chem. Eng. Data, 2012, 57, 1525–1533.
c
2202 New J. Chem., 2013, 37, 2196--2202
This journal is The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2013